Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $1.465B (100.0% shares, 0.0% debt)

Holdings (35)

— MERUS N V 12.9%

Value $189M Shares 3,200,000 Est. Cost $25.16 Unrealized —

NUVL NUVALENT INC 7.7%

Value $113M Shares 1,487,756 Est. Cost $45.30 Unrealized +57.0%

XENE XENON PHARMACEUTICALS INC 7.3%

Value $107M Shares 2,754,266 Est. Cost $30.11 Unrealized +32.8%

PCVX VAXCYTE INC 6.7%

Value $98.54M Shares 1,305,000 Est. Cost $53.62 Unrealized +26.9%

ELVN ENLIVEN THERAPEUTICS INC 6.3%

Value $92.85M Shares 3,973,245 Est. Cost $18.48 Unrealized +13.9%

VERA VERA THERAPEUTICS INC 6.1%

Value $89.55M Shares 2,475,000 Est. Cost $8.35 Unrealized +375.0%

COGT COGENT BIOSCIENCES INC 5.6%

Value $82.09M Shares 9,738,000 Est. Cost $8.23 Unrealized -7.8%

SLNO SOLENO THERAPEUTICS INC 4.0%

Value $58.14M Shares 1,425,000 Est. Cost $38.06 Unrealized +11.4%

CLDX CELLDEX THERAPEUTICS INC NEW 3.6%

Value $52.74M Shares 1,425,000 Est. Cost $34.85 Unrealized +8.3%

— MIND MEDICINE MINDMED INC 3.5%

Value $51.52M Shares 7,145,888 Est. Cost $9.00 Unrealized —

RYTM RHYTHM PHARMACEUTICALS INC 3.4%

Value $50.3M Shares 1,225,000 Est. Cost $24.90 Unrealized +60.3%

ARVN ARVINAS INC 3.4%

Value $50.16M Shares 1,884,361 Est. Cost $29.08 Unrealized +9.5%

SYRE SPYRE THERAPEUTICS INC 3.2%

Value $46.74M Shares 1,988,084 Est. Cost $14.79 Unrealized +128.1%

CATX PERSPECTIVE THERAPEUTICS INC 3.2%

Value $46.43M Shares 4,657,345 Est. Cost $14.46 Unrealized 0.0%

PHVS PHARVARIS N V 2.3%

Value $34.03M Shares 1,810,175 Est. Cost $23.47 Unrealized -13.3%

ALKS ALKERMES PLC 2.3%

Value $33.14M Shares 1,375,000 Est. Cost $24.53 Unrealized 0.0%

VRDN VIRIDIAN THERAPEUTICS INC 2.2%

Value $32.89M Shares 2,528,032 Est. Cost $16.71 Unrealized -17.1%

KURA KURA ONCOLOGY INC 2.2%

Value $32.81M Shares 1,593,350 Est. Cost $15.17 Unrealized +35.5%

NKTX NKARTA INC 1.7%

Value $24.53M Shares 4,151,034 Est. Cost $4.47 Unrealized +58.1%

CELC CELCUITY INC 1.6%

Value $23.98M Shares 1,464,105 Est. Cost $18.27 Unrealized -8.5%

— THIRD HARMONIC BIO INC 1.4%

Value $20.09M Shares 1,545,426 Est. Cost $12.09 Unrealized —

IMVT IMMUNOVANT INC 1.4%

Value $19.83M Shares 750,990 Est. Cost $14.46 Unrealized +96.8%

ABVX ABIVAX SA 1.2%

Value $16.98M Shares 1,284,110 Est. Cost $10.70 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 1.2%

Value $16.94M Shares 825,000 Est. Cost $21.46 Unrealized -2.5%

CCCC C4 THERAPEUTICS INC 1.1%

Value $15.76M Shares 3,410,384 Est. Cost $2.28 Unrealized +161.6%

ORIC ORIC PHARMACEUTICALS INC 1.0%

Value $14.14M Shares 2,000,000 Est. Cost $11.88 Unrealized -24.6%

APGE APOGEE THERAPEUTICS INC 0.8%

Value $11.41M Shares 290,000 Est. Cost $25.01 Unrealized +94.0%

CABA CABALETTA BIO INC 0.6%

Value $8.228M Shares 1,100,000 Est. Cost $7.66 Unrealized +60.1%

PCSC PERCEPTIVE CAP SOLUTIONS COR 0.5%

Value $7.545M Shares 750,000 Est. Cost $10.07 Unrealized 0.0%

NGNE NEUROGENE INC 0.5%

Value $7.278M Shares 200,000 Est. Cost $33.40 Unrealized +5.6%

VTGN VISTAGEN THERAPEUTICS INC 0.4%

Value $5.481M Shares 1,575,000 Est. Cost $4.44 Unrealized -2.5%

BBOT HELIX ACQUISITION CORP II 0.3%

Value $5.11M Shares 500,000 Est. Cost $10.35 Unrealized -0.6%

AUTL AUTOLUS THERAPEUTICS PLC 0.3%

Value $4.102M Shares 1,178,723 Est. Cost $6.38 Unrealized —

— ARCA BIOPHARMA INC 0.1%

Value $1.587M Shares 414,325 Est. Cost $3.83 Unrealized —

AVTX AVALO THERAPEUTICS INC 0.0%

Value $499K Shares 40,000 Est. Cost $12.97 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	3,200,000	$189M	12.9%	$25.16	—	COM	N5749R100
NUVL	NUVALENT INC	1,487,756	$113M	7.7%	$45.30	+57.0%	COM	670703107
XENE	XENON PHARMACEUTICALS INC	2,754,266	$107M	7.3%	$30.11	+32.8%	COM	98420N105
PCVX	VAXCYTE INC	1,305,000	$98.54M	6.7%	$53.62	+26.9%	COM	92243G108
ELVN	ENLIVEN THERAPEUTICS INC	3,973,245	$92.85M	6.3%	$18.48	+13.9%	COM	29337E102
VERA	VERA THERAPEUTICS INC	2,475,000	$89.55M	6.1%	$8.35	+375.0%	CL A	92337R101
COGT	COGENT BIOSCIENCES INC	9,738,000	$82.09M	5.6%	$8.23	-7.8%	COM	19240Q201
SLNO	SOLENO THERAPEUTICS INC	1,425,000	$58.14M	4.0%	$38.06	+11.4%	COM	834203309
CLDX	CELLDEX THERAPEUTICS INC NEW	1,425,000	$52.74M	3.6%	$34.85	+8.3%	COM NEW	15117B202
—	MIND MEDICINE MINDMED INC	7,145,888	$51.52M	3.5%	$9.00	—	COM NEW	60255C885
RYTM	RHYTHM PHARMACEUTICALS INC	1,225,000	$50.3M	3.4%	$24.90	+60.3%	COM	76243J105
ARVN	ARVINAS INC	1,884,361	$50.16M	3.4%	$29.08	+9.5%	COM	04335A105
SYRE	SPYRE THERAPEUTICS INC	1,988,084	$46.74M	3.2%	$14.79	+128.1%	COM NEW	00773J202
CATX	PERSPECTIVE THERAPEUTICS INC	4,657,345	$46.43M	3.2%	$14.46	0.0%	COM NEW	46489V302
PHVS	PHARVARIS N V	1,810,175	$34.03M	2.3%	$23.47	-13.3%	COM	N69605108
ALKS	ALKERMES PLC	1,375,000	$33.14M	2.3%	$24.53	0.0%	SHS	G01767105
VRDN	VIRIDIAN THERAPEUTICS INC	2,528,032	$32.89M	2.2%	$16.71	-17.1%	COM	92790C104
KURA	KURA ONCOLOGY INC	1,593,350	$32.81M	2.2%	$15.17	+35.5%	COM	50127T109
NKTX	NKARTA INC	4,151,034	$24.53M	1.7%	$4.47	+58.1%	COM	65487U108
CELC	CELCUITY INC	1,464,105	$23.98M	1.6%	$18.27	-8.5%	COM	15102K100
—	THIRD HARMONIC BIO INC	1,545,426	$20.09M	1.4%	$12.09	—	COM	88427A107
IMVT	IMMUNOVANT INC	750,990	$19.83M	1.4%	$14.46	+96.8%	COM	45258J102
ABVX	ABIVAX SA	1,284,110	$16.98M	1.2%	$10.70	—	SPONSORED ADS	00370M103
SNDX	SYNDAX PHARMACEUTICALS INC	825,000	$16.94M	1.2%	$21.46	-2.5%	COM	87164F105
CCCC	C4 THERAPEUTICS INC	3,410,384	$15.76M	1.1%	$2.28	+161.6%	COM STK	12529R107
ORIC	ORIC PHARMACEUTICALS INC	2,000,000	$14.14M	1.0%	$11.88	-24.6%	COM	68622P109
APGE	APOGEE THERAPEUTICS INC	290,000	$11.41M	0.8%	$25.01	+94.0%	COM	03770N101
CABA	CABALETTA BIO INC	1,100,000	$8.228M	0.6%	$7.66	+60.1%	COM	12674W109
PCSC	PERCEPTIVE CAP SOLUTIONS COR	750,000	$7.545M	0.5%	$10.07	0.0%	CL A ORD SHS	G70077105
NGNE	NEUROGENE INC	200,000	$7.278M	0.5%	$33.40	+5.6%	COM	64135M105
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$5.481M	0.4%	$4.44	-2.5%	COM	92840H400
BBOT	HELIX ACQUISITION CORP II	500,000	$5.11M	0.3%	$10.35	-0.6%	CL A ORD SHS	G4444H101
AUTL	AUTOLUS THERAPEUTICS PLC	1,178,723	$4.102M	0.3%	$6.38	—	SPON ADS	05280R100
—	ARCA BIOPHARMA INC	414,325	$1.587M	0.1%	$3.83	—	COM	00211Y506
AVTX	AVALO THERAPEUTICS INC	40,000	$499K	0.0%	$12.97	0.0%	COM NEW	05338F306